Case report: successful pregnancy and delivery after myocardial infarction and essential thrombocythemia treated with clopidrogel.
We describe a case of a woman with essential thrombocythemia (ET) who had a subsequent successful pregnancy after a myocardial infarction and aortocoronary bypass grafting. We report the therapeutic management with clopidogrel and low molecular weight heparin. A healthy child was born spontaneously after 41 weeks of pregnancy. The placenta was morphologically normal. No maternal cardiac problems occurred.
Klinzing
P
P
Friedrich-Schiller Universität Jena, University Women's Hospital, Gernany.
Markert
U R
UR
Liesaus
K
K
Peiker
G
G
D000328:Adult; D000077144:Clopidogrel; D001026:Coronary Artery Bypass; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011256:Pregnancy Outcome; D013922:Thrombocytosis / Q000150:complications / Q000188:drug therapy*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine